Akbay Ayşegül YARPUZLU, Ayşe NAZİKOĞLU, Yeşim UĞUR, Esin ASAN, İlkay YILDIZ

Investigation of renal histopathological changes due to HIV-RT inhibitor 2-phenowymethyl-5-chlorobenzimidazole administration in rats

2-phenoxymethyl-5-chlorobenzimidazole is a newly synthesized Human Immunodeficiency Virus- Reverse Transcriptase (HIV-RT) inhibitor. In a previous study it was found that this chemical entity was partially secreted and possibly metabolized in the liver of rats depending on histological data. This study was aimed to investigate the histological changes in the kidneys of rats receiving 2-phenoxymethyl-5-chlorobenzimidazole intramuscularly dissolved in dimethylsulfoxide (DMSO) injected as a single and consecutive 7 doses (5mg/kg) within 14 days with respect to the control group without any intervention. Additionally control experiments to observe the possible effects of the solvent DMSO were also designed. The results indicated that; there is minor toxicity in the renal tubular epithelia disrupting the reabsorbtion and secretion functions of the tubules as both DMSO and 2-phenoxymethyl-5-chlorobenzimidazole are hydrophobic and have capacity to distract membranous fractions of the cells.

PDF

___

Fishman JA. Treatment of Infection Due to Pneumocystis carini. Antimicrobial Agents and Chemotherapy. 1998; 42;6:1309-1314.
Hof H. Critical Annotations to the Use of Azole Antifungals for Plant Protection. Antimicrobial Agents Chemother. 2001; 45;11:2987-2990.
Chiba N, von Zanten SJ, Sinclair P, Ferguson RA, Escobedo S, Grace E. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive ( CADET-Hp) randomised controlled trial. BMJ2002,324;7344:1012.
Buerger I, Reefschlaeger J, Bender W, Eckenberg P, Popp A, Weber O, Graeger S, Klenk HD, Ruebsamen.Waigmann H, Hallenberger S. A Novel Nonnucleoside Inhibitor Specifically Targets Cytomegalovirus DNA Maturation via the UL89 and UL56 Gene Products. J. Virol.2001,75:19:9077-9086.
Adam RD. Biology of Giardia lamblia. Clin Microbiol Rev. 2001,14;3:447-475.
Ridoux O, Drancourt M. In vitro Susceptibilies of the Microsporidia Encephalitozoon cuniculi, Encephalitozoon hellem and Encephalitozoon intestinalis to Albendozole and its sulfoxide and sulfone Metabolites. Antimicrob Agents Chemother. 1998,42 ;12:3301-3303.
Morrissette NS. Sibley LD. Cytoskeleton to Amplicomplexon Parasites. Microbiol Mol Biol Rev. 2002,66;1:21-38.
Akbay A, Ören !, Temiz-Arpacı Ö, Akı-Şener E, Yalçın İ. Synthesis and HIV-1 Reverse transcriptase Inhibitor Activity of Some 2,5,6-Substituted Benzoxazole, Benzimidazole, Benzthiazole and Oxazolo (4,5-b) pyridine Derivatives. ArzneimForschDrugRes. 2003,53:4:266-71.
Yarpuzlu Akbay A, Yıldız İ, Temiz-Arpacı Ö, Karagenç N, Aki-Şener E, Yalçın İ. Adenosine Deaminase Inhibitor Activity of Some Benzoxazole, Benzimidazole and Oxazolo (4,5-b) pyridine Derivatives. XIII. Biyoteknoloji Kongresi Bildiriler Kitabı, 25-29 Ağustos 2003 Çanakkale sf.21-26.
Arterburn LM, Zurlo J, Yager JD, Overton RM, HeifetzAH. A morphological study of differentiated hepatocytes in vitro. Hepatology. 1995,22; 1:175-187,1995.
Associated Intestinal Tract Organs, Part 25 Liver, pages:575-591 in Histology for Pathologists, edited by Stemberg SS. Second edition, Lippincott-Raven Publishers 1997, Philadelphia.